What is the current Genedrive market capitalization?
The current market capitalization of Genedrive is 2.18 M GBP.
Genedrive Market capitalization 2024
Genedrive Market capitalization
2.18 M GBP
Ticker
GDR.L
ISIN
GB00B1VKB244
WKN
A0ML2T
In 2024, Genedrive's market cap stood at 2.18 M GBP, a -81.48% increase from the 11.76 M GBP market cap in the previous year.
The Genedrive Market capitalization history
| YEAR | Market Capitalization (undefined GBP) |
|---|---|
| 2023 | 19.65 |
| 2022 | 19.29 |
| 2021 | 52.69 |
| 2020 | 27.6 |
| 2019 | 5.43 |
| 2018 | 5.85 |
| 2017 | 7.73 |
| 2016 | 9.03 |
| 2015 | 22.74 |
| 2014 | 30.89 |
| 2013 | 46.11 |
| 2012 | 37.68 |
| 2011 | 33.63 |
| 2010 | 34.06 |
| 2009 | 25.88 |
| 2008 | 12.08 |
| 2007 | 10.74 |
| 2006 | - |
| 2005 | - |
| 2004 | - |
Genedrive Aktienanalyse
What does Genedrive do?
Genedrive PLC is a biomedical company based in Manchester, United Kingdom, specializing in the development of innovative diagnostic tests for infectious diseases and cancer. The company was founded in 2007 under the name Epistem Limited and went public in 2013. The business model of Genedrive involves developing and distributing innovative molecular diagnostic tests for diseases worldwide. The company's main goal is to change the way infectious diseases and cancer are diagnosed and treated by offering rapid, accurate, and cost-effective tests. The company has two main divisions: Genprobe and Instruments. Under Genprobe, various in vitro diagnostic tests for infectious diseases and diseases of the human immune system, including tuberculosis, hepatitis C, hepatitis B, HIV, and others, are offered. Under Instruments, Genedrive offers PCR instruments used for analyzing samples for DNA and RNA sequences. Some of Genedrive's key products include: - Genedrive HCV-ID Testkit: A test kit for identifying and quantifying hepatitis C viruses (HCV) in human blood samples. The test provides results within 90 minutes and has high accuracy. - Genedrive MT-RNR1 Testkit: A test kit for the rapid diagnosis of tuberculosis (TB), one of the most common infectious diseases worldwide. The test utilizes PCR technology and provides results within 90 minutes. - Genedrive Genedrive 96: An instrument for simultaneous analysis of up to 96 PCR samples. The system offers high accuracy and precision in analyzing RNA and DNA sequences. The company collaborates closely with leading research institutions and health organizations worldwide to improve its products and develop new tests. Genedrive has formed partnerships with the British government, the US Department of Defense, and other institutions. In recent years, the company has made significant progress in developing new diagnostic tests for infectious diseases and cancer. For example, Genedrive recently signed an agreement with the Foundation for Innovative New Diagnostics (FIND) to develop a molecular test for the Ebola virus. The company also has a pipeline of projects, including tests for COVID-19 and antibiotic resistance. Despite Genedrive's success, the company remains committed to innovation and research in order to transform the diagnostics industry and improve the health of people worldwide. Genedrive is expected to continue playing an important role in the fight against infectious diseases and cancer in the future. Genedrive ist eines der beliebtesten Unternehmen auf Eulerpool.com.Market capitalization Details
Exploring Genedrive's Market Capitalization
Genedrive's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.
Year-to-Year Comparison
A yearly comparison of Genedrive's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.
Impact on Investments
Genedrive's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.
Interpreting Market Capitalization Fluctuations
Variations in Genedrive’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.
Frequently Asked Questions about Genedrive stock
What is market capitalization?
The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Genedrive.
How has the market capitalization of Genedrive developed in recent years?
The market capitalization of Genedrive has increased/decreased by -81.48% compared to the previous year.
What does market capitalization mean for investors?
The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.
Why is market capitalization an important indicator for investors?
The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.
Why does the market capitalization fluctuate?
The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.
What role does market capitalization play in the valuation of Genedrive?
In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.
Does the market capitalization influence the performance of Genedrive?
There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
Does the market capitalization of Genedrive have an influence on indices?
Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).
How much dividend does Genedrive pay?
Over the past 12 months, Genedrive paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Genedrive is expected to pay a dividend of 0 GBP.
What is the dividend yield of Genedrive?
The current dividend yield of Genedrive is .
When does Genedrive pay dividends?
Genedrive pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Genedrive?
Genedrive paid dividends every year for the past 0 years.
What is the dividend of Genedrive?
For the upcoming 12 months, dividends amounting to 0 GBP are expected. This corresponds to a dividend yield of 0 %.
In which sector is Genedrive located?
Genedrive is assigned to the 'Health' sector.
Wann musste ich die Aktien von Genedrive kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Genedrive from 9/21/2024 amounting to 0 GBP, you needed to have the stock in your portfolio before the ex-date on 9/21/2024.
When did Genedrive pay the last dividend?
The last dividend was paid out on 9/21/2024.
What was the dividend of Genedrive in the year 2023?
In the year 2023, Genedrive distributed 0 GBP as dividends.
In which currency does Genedrive pay out the dividend?
The dividends of Genedrive are distributed in GBP.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Genedrive
Our stock analysis for Genedrive Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Genedrive Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
